company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
"Millendo Therapeutics, Inc.",MLND,,0001544227,2011.0,Q3,,2011-12-31,2012-11-13 13:25:18+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,4541000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2011.0,Q3,,2011-12-31,2012-11-13 13:25:18+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,44000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2011.0,Q3,,2011-12-31,2012-11-13 13:25:18+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,4585000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2011.0,Q3,,2011-12-31,2012-11-13 13:25:18+00:00,,totalassets,Total Assets,=,debit,usd,4585000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2011.0,Q3,,2011-12-31,2012-11-13 13:25:18+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,276000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2011.0,Q3,,2011-12-31,2012-11-13 13:25:18+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,399000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2011.0,Q3,,2011-12-31,2012-11-13 13:25:18+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,675000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2011.0,Q3,,2011-12-31,2012-11-13 13:25:18+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,87000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2011.0,Q3,,2011-12-31,2012-11-13 13:25:18+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,87000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2011.0,Q3,,2011-12-31,2012-11-13 13:25:18+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,762000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2011.0,Q3,,2011-12-31,2012-11-13 13:25:18+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2011.0,Q3,,2011-12-31,2012-11-13 13:25:18+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,6200000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2011.0,Q3,,2011-12-31,2012-11-13 13:25:18+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2011.0,Q3,,2011-12-31,2012-11-13 13:25:18+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,247000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2011.0,Q3,,2011-12-31,2012-11-13 13:25:18+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-2624000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2011.0,Q3,,2011-12-31,2012-11-13 13:25:18+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-2377000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2011.0,Q3,,2011-12-31,2012-11-13 13:25:18+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-2377000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2011.0,Q3,,2011-12-31,2012-11-13 13:25:18+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-2377000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2011.0,Q3,,2011-12-31,2012-11-13 13:25:18+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,4585000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,,2012-06-30,2012-08-14 13:36:25+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,34067000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,,2012-06-30,2012-08-14 13:36:25+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,209000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,,2012-06-30,2012-08-14 13:36:25+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,34276000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,,2012-06-30,2012-08-14 13:36:25+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,434000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,,2012-06-30,2012-08-14 13:36:25+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,275000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,,2012-06-30,2012-08-14 13:36:25+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,275000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,,2012-06-30,2012-08-14 13:36:25+00:00,,totalassets,Total Assets,=,debit,usd,34985000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,,2012-06-30,2012-08-14 13:36:25+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,605000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,,2012-06-30,2012-08-14 13:36:25+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1205000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,,2012-06-30,2012-08-14 13:36:25+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1810000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,,2012-06-30,2012-08-14 13:36:25+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1810000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,,2012-06-30,2012-08-14 13:36:25+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,,2012-06-30,2012-08-14 13:36:25+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,41192000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,,2012-06-30,2012-08-14 13:36:25+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,807000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,,2012-06-30,2012-08-14 13:36:25+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-8824000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,,2012-06-30,2012-08-14 13:36:25+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-8017000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,,2012-06-30,2012-08-14 13:36:25+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-8017000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,,2012-06-30,2012-08-14 13:36:25+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-8017000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,,2012-06-30,2012-08-14 13:36:25+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,34985000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,,2012-09-30,2012-11-13 13:25:18+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,35119000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,,2012-09-30,2012-11-13 13:25:18+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,460000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,,2012-09-30,2012-11-13 13:25:18+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,35579000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,,2012-09-30,2012-11-13 13:25:18+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,654000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,,2012-09-30,2012-11-13 13:25:18+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,93000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,,2012-09-30,2012-11-13 13:25:18+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,93000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,,2012-09-30,2012-11-13 13:25:18+00:00,,totalassets,Total Assets,=,debit,usd,36326000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,,2012-09-30,2012-11-13 13:25:18+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1069000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,,2012-09-30,2012-11-13 13:25:18+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,845000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,,2012-09-30,2012-11-13 13:25:18+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1914000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,,2012-09-30,2012-11-13 13:25:18+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1914000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,,2012-09-30,2012-11-13 13:25:18+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,,2012-09-30,2012-11-13 13:25:18+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,,2012-09-30,2012-11-13 13:25:18+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,46354000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,,2012-09-30,2012-11-13 13:25:18+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-11942000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,,2012-09-30,2012-11-13 13:25:18+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,34412000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,,2012-09-30,2012-11-13 13:25:18+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,34412000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,,2012-09-30,2012-11-13 13:25:18+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,34412000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,,2012-09-30,2012-11-13 13:25:18+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,36326000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,,2013-03-31,2013-05-15 13:19:06+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,43188000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,,2013-03-31,2013-05-15 13:19:06+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,16515000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,,2013-03-31,2013-05-15 13:19:06+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,481000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,,2013-03-31,2013-05-15 13:19:06+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,60184000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,,2013-03-31,2013-05-15 13:19:06+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,895000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,,2013-03-31,2013-05-15 13:19:06+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,88000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,,2013-03-31,2013-05-15 13:19:06+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,88000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,,2013-03-31,2013-05-15 13:19:06+00:00,,totalassets,Total Assets,=,debit,usd,61167000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,,2013-03-31,2013-05-15 13:19:06+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,948000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,,2013-03-31,2013-05-15 13:19:06+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1146000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,,2013-03-31,2013-05-15 13:19:06+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,2094000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,,2013-03-31,2013-05-15 13:19:06+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,11000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,,2013-03-31,2013-05-15 13:19:06+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,11000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,,2013-03-31,2013-05-15 13:19:06+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,2105000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,,2013-03-31,2013-05-15 13:19:06+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,,2013-03-31,2013-05-15 13:19:06+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,,2013-03-31,2013-05-15 13:19:06+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,80352000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,,2013-03-31,2013-05-15 13:19:06+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-21291000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,,2013-03-31,2013-05-15 13:19:06+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,,2013-03-31,2013-05-15 13:19:06+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,59062000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,,2013-03-31,2013-05-15 13:19:06+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,59062000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,,2013-03-31,2013-05-15 13:19:06+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,59062000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,,2013-03-31,2013-05-15 13:19:06+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,61167000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,,2013-06-30,2013-08-13 10:45:12+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,28193000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,,2013-06-30,2013-08-13 10:45:12+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,26152000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,,2013-06-30,2013-08-13 10:45:12+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,917000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,,2013-06-30,2013-08-13 10:45:12+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,55262000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,,2013-06-30,2013-08-13 10:45:12+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,890000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,,2013-06-30,2013-08-13 10:45:12+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,88000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,,2013-06-30,2013-08-13 10:45:12+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,88000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,,2013-06-30,2013-08-13 10:45:12+00:00,,totalassets,Total Assets,=,debit,usd,56240000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,,2013-06-30,2013-08-13 10:45:12+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,216000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,,2013-06-30,2013-08-13 10:45:12+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1596000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,,2013-06-30,2013-08-13 10:45:12+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1812000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,,2013-06-30,2013-08-13 10:45:12+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,15000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,,2013-06-30,2013-08-13 10:45:12+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,15000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,,2013-06-30,2013-08-13 10:45:12+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1827000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,,2013-06-30,2013-08-13 10:45:12+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,,2013-06-30,2013-08-13 10:45:12+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,81726000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,,2013-06-30,2013-08-13 10:45:12+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-27287000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,,2013-06-30,2013-08-13 10:45:12+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-26000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,,2013-06-30,2013-08-13 10:45:12+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,54413000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,,2013-06-30,2013-08-13 10:45:12+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,54413000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,,2013-06-30,2013-08-13 10:45:12+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,54413000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,,2013-06-30,2013-08-13 10:45:12+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,56240000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q3,,2013-09-30,2013-11-13 16:30:51+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,21077000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q3,,2013-09-30,2013-11-13 16:30:51+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,28489000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q3,,2013-09-30,2013-11-13 16:30:51+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,841000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q3,,2013-09-30,2013-11-13 16:30:51+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,50407000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q3,,2013-09-30,2013-11-13 16:30:51+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,730000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q3,,2013-09-30,2013-11-13 16:30:51+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,88000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q3,,2013-09-30,2013-11-13 16:30:51+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,88000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q3,,2013-09-30,2013-11-13 16:30:51+00:00,,totalassets,Total Assets,=,debit,usd,51225000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q3,,2013-09-30,2013-11-13 16:30:51+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,791000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q3,,2013-09-30,2013-11-13 16:30:51+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1365000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q3,,2013-09-30,2013-11-13 16:30:51+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,2156000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q3,,2013-09-30,2013-11-13 16:30:51+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,65000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q3,,2013-09-30,2013-11-13 16:30:51+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,65000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q3,,2013-09-30,2013-11-13 16:30:51+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,2221000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q3,,2013-09-30,2013-11-13 16:30:51+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q3,,2013-09-30,2013-11-13 16:30:51+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,83179000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q3,,2013-09-30,2013-11-13 16:30:51+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-34178000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q3,,2013-09-30,2013-11-13 16:30:51+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,3000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q3,,2013-09-30,2013-11-13 16:30:51+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,49004000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q3,,2013-09-30,2013-11-13 16:30:51+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,49004000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q3,,2013-09-30,2013-11-13 16:30:51+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,49004000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q3,,2013-09-30,2013-11-13 16:30:51+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,51225000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q1,,2014-03-31,2014-05-08 08:07:59+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,56134000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q1,,2014-03-31,2014-05-08 08:07:59+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,33331000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q1,,2014-03-31,2014-05-08 08:07:59+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,605000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q1,,2014-03-31,2014-05-08 08:07:59+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,90070000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q1,,2014-03-31,2014-05-08 08:07:59+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1202000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q1,,2014-03-31,2014-05-08 08:07:59+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1403000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q1,,2014-03-31,2014-05-08 08:07:59+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,88000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q1,,2014-03-31,2014-05-08 08:07:59+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1491000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q1,,2014-03-31,2014-05-08 08:07:59+00:00,,totalassets,Total Assets,=,debit,usd,92763000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q1,,2014-03-31,2014-05-08 08:07:59+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1943000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q1,,2014-03-31,2014-05-08 08:07:59+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4344000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q1,,2014-03-31,2014-05-08 08:07:59+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6287000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q1,,2014-03-31,2014-05-08 08:07:59+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,74000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q1,,2014-03-31,2014-05-08 08:07:59+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,74000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q1,,2014-03-31,2014-05-08 08:07:59+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,6361000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q1,,2014-03-31,2014-05-08 08:07:59+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q1,,2014-03-31,2014-05-08 08:07:59+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,139397000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q1,,2014-03-31,2014-05-08 08:07:59+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-52992000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q1,,2014-03-31,2014-05-08 08:07:59+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-3000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q1,,2014-03-31,2014-05-08 08:07:59+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,86402000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q1,,2014-03-31,2014-05-08 08:07:59+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,86402000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q1,,2014-03-31,2014-05-08 08:07:59+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,86402000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q1,,2014-03-31,2014-05-08 08:07:59+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,92763000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q2,,2014-06-30,2014-08-07 09:05:51+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,16553000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q2,,2014-06-30,2014-08-07 09:05:51+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,64815000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q2,,2014-06-30,2014-08-07 09:05:51+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1247000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q2,,2014-06-30,2014-08-07 09:05:51+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,82615000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q2,,2014-06-30,2014-08-07 09:05:51+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1909000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q2,,2014-06-30,2014-08-07 09:05:51+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1108000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q2,,2014-06-30,2014-08-07 09:05:51+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,197000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q2,,2014-06-30,2014-08-07 09:05:51+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1305000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q2,,2014-06-30,2014-08-07 09:05:51+00:00,,totalassets,Total Assets,=,debit,usd,85829000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q2,,2014-06-30,2014-08-07 09:05:51+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1408000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q2,,2014-06-30,2014-08-07 09:05:51+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5646000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q2,,2014-06-30,2014-08-07 09:05:51+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,7054000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q2,,2014-06-30,2014-08-07 09:05:51+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,78000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q2,,2014-06-30,2014-08-07 09:05:51+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,78000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q2,,2014-06-30,2014-08-07 09:05:51+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,7132000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q2,,2014-06-30,2014-08-07 09:05:51+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q2,,2014-06-30,2014-08-07 09:05:51+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,141590000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q2,,2014-06-30,2014-08-07 09:05:51+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-62885000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q2,,2014-06-30,2014-08-07 09:05:51+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-8000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q2,,2014-06-30,2014-08-07 09:05:51+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,78697000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q2,,2014-06-30,2014-08-07 09:05:51+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,78697000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q2,,2014-06-30,2014-08-07 09:05:51+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,78697000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q2,,2014-06-30,2014-08-07 09:05:51+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,85829000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,,2014-09-30,2014-11-10 07:37:12+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,12125000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,,2014-09-30,2014-11-10 07:37:12+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,60041000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,,2014-09-30,2014-11-10 07:37:12+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1448000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,,2014-09-30,2014-11-10 07:37:12+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,73614000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,,2014-09-30,2014-11-10 07:37:12+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3103000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,,2014-09-30,2014-11-10 07:37:12+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,585000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,,2014-09-30,2014-11-10 07:37:12+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,197000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,,2014-09-30,2014-11-10 07:37:12+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,782000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,,2014-09-30,2014-11-10 07:37:12+00:00,,totalassets,Total Assets,=,debit,usd,77499000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,,2014-09-30,2014-11-10 07:37:12+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2983000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,,2014-09-30,2014-11-10 07:37:12+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5820000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,,2014-09-30,2014-11-10 07:37:12+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,8803000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,,2014-09-30,2014-11-10 07:37:12+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,71000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,,2014-09-30,2014-11-10 07:37:12+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,71000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,,2014-09-30,2014-11-10 07:37:12+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,8874000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,,2014-09-30,2014-11-10 07:37:12+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,,2014-09-30,2014-11-10 07:37:12+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,144457000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,,2014-09-30,2014-11-10 07:37:12+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-75808000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,,2014-09-30,2014-11-10 07:37:12+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-24000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,,2014-09-30,2014-11-10 07:37:12+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,68625000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,,2014-09-30,2014-11-10 07:37:12+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,68625000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,,2014-09-30,2014-11-10 07:37:12+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,68625000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,,2014-09-30,2014-11-10 07:37:12+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,77499000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,,2015-03-31,2015-05-11 16:12:27+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,134698000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,,2015-03-31,2015-05-11 16:12:27+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,109000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,,2015-03-31,2015-05-11 16:12:27+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,34641000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,,2015-03-31,2015-05-11 16:12:27+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1886000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,,2015-03-31,2015-05-11 16:12:27+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,171334000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,,2015-03-31,2015-05-11 16:12:27+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4159000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,,2015-03-31,2015-05-11 16:12:27+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,196000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,,2015-03-31,2015-05-11 16:12:27+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,88000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,,2015-03-31,2015-05-11 16:12:27+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,284000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,,2015-03-31,2015-05-11 16:12:27+00:00,,totalassets,Total Assets,=,debit,usd,175777000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,,2015-03-31,2015-05-11 16:12:27+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2493000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,,2015-03-31,2015-05-11 16:12:27+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4116000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,,2015-03-31,2015-05-11 16:12:27+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6609000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,,2015-03-31,2015-05-11 16:12:27+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,74000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,,2015-03-31,2015-05-11 16:12:27+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,74000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,,2015-03-31,2015-05-11 16:12:27+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,6683000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,,2015-03-31,2015-05-11 16:12:27+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,,2015-03-31,2015-05-11 16:12:27+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,280999000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,,2015-03-31,2015-05-11 16:12:27+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-111904000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,,2015-03-31,2015-05-11 16:12:27+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,,2015-03-31,2015-05-11 16:12:27+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,169094000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,,2015-03-31,2015-05-11 16:12:27+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,169094000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,,2015-03-31,2015-05-11 16:12:27+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,169094000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,,2015-03-31,2015-05-11 16:12:27+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,175777000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,,2015-06-30,2015-08-10 16:09:10+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,70238000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,,2015-06-30,2015-08-10 16:09:10+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,109000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,,2015-06-30,2015-08-10 16:09:10+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,85381000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,,2015-06-30,2015-08-10 16:09:10+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3434000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,,2015-06-30,2015-08-10 16:09:10+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,159162000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,,2015-06-30,2015-08-10 16:09:10+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4208000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,,2015-06-30,2015-08-10 16:09:10+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,557000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,,2015-06-30,2015-08-10 16:09:10+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,,2015-06-30,2015-08-10 16:09:10+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,527000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,,2015-06-30,2015-08-10 16:09:10+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1084000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,,2015-06-30,2015-08-10 16:09:10+00:00,,totalassets,Total Assets,=,debit,usd,164454000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,,2015-06-30,2015-08-10 16:09:10+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2987000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,,2015-06-30,2015-08-10 16:09:10+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4611000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,,2015-06-30,2015-08-10 16:09:10+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,7598000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,,2015-06-30,2015-08-10 16:09:10+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,149000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,,2015-06-30,2015-08-10 16:09:10+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,149000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,,2015-06-30,2015-08-10 16:09:10+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,7747000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,,2015-06-30,2015-08-10 16:09:10+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,,2015-06-30,2015-08-10 16:09:10+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,286195000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,,2015-06-30,2015-08-10 16:09:10+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-129394000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,,2015-06-30,2015-08-10 16:09:10+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-94000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,,2015-06-30,2015-08-10 16:09:10+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,156707000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,,2015-06-30,2015-08-10 16:09:10+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,156707000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,,2015-06-30,2015-08-10 16:09:10+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,156707000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,,2015-06-30,2015-08-10 16:09:10+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,164454000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,,2015-09-30,2015-11-05 16:38:18+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,50842000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,,2015-09-30,2015-11-05 16:38:18+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,109000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,,2015-09-30,2015-11-05 16:38:18+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,90830000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,,2015-09-30,2015-11-05 16:38:18+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3541000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,,2015-09-30,2015-11-05 16:38:18+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,145322000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,,2015-09-30,2015-11-05 16:38:18+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6717000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,,2015-09-30,2015-11-05 16:38:18+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,241000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,,2015-09-30,2015-11-05 16:38:18+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,,2015-09-30,2015-11-05 16:38:18+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,527000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,,2015-09-30,2015-11-05 16:38:18+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,768000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,,2015-09-30,2015-11-05 16:38:18+00:00,,totalassets,Total Assets,=,debit,usd,152807000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,,2015-09-30,2015-11-05 16:38:18+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4156000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,,2015-09-30,2015-11-05 16:38:18+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5707000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,,2015-09-30,2015-11-05 16:38:18+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,9863000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,,2015-09-30,2015-11-05 16:38:18+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,358000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,,2015-09-30,2015-11-05 16:38:18+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,358000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,,2015-09-30,2015-11-05 16:38:18+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,10221000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,,2015-09-30,2015-11-05 16:38:18+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,,2015-09-30,2015-11-05 16:38:18+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,289974000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,,2015-09-30,2015-11-05 16:38:18+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-147316000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,,2015-09-30,2015-11-05 16:38:18+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-72000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,,2015-09-30,2015-11-05 16:38:18+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,142586000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,,2015-09-30,2015-11-05 16:38:18+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,142586000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,,2015-09-30,2015-11-05 16:38:18+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,142586000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,,2015-09-30,2015-11-05 16:38:18+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,152807000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,,2016-03-31,2016-05-05 16:20:58+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,20478000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,,2016-03-31,2016-05-05 16:20:58+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,109000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,,2016-03-31,2016-05-05 16:20:58+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,89610000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,,2016-03-31,2016-05-05 16:20:58+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2542000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,,2016-03-31,2016-05-05 16:20:58+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,112739000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,,2016-03-31,2016-05-05 16:20:58+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,8667000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,,2016-03-31,2016-05-05 16:20:58+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,215000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,,2016-03-31,2016-05-05 16:20:58+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,439000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,,2016-03-31,2016-05-05 16:20:58+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,654000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,,2016-03-31,2016-05-05 16:20:58+00:00,,totalassets,Total Assets,=,debit,usd,122060000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,,2016-03-31,2016-05-05 16:20:58+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4218000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,,2016-03-31,2016-05-05 16:20:58+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7589000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,,2016-03-31,2016-05-05 16:20:58+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,11807000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,,2016-03-31,2016-05-05 16:20:58+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1409000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,,2016-03-31,2016-05-05 16:20:58+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1409000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,,2016-03-31,2016-05-05 16:20:58+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,13216000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,,2016-03-31,2016-05-05 16:20:58+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,,2016-03-31,2016-05-05 16:20:58+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,298526000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,,2016-03-31,2016-05-05 16:20:58+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-189675000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,,2016-03-31,2016-05-05 16:20:58+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-7000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,,2016-03-31,2016-05-05 16:20:58+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,108844000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,,2016-03-31,2016-05-05 16:20:58+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,108844000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,,2016-03-31,2016-05-05 16:20:58+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,108844000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,,2016-03-31,2016-05-05 16:20:58+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,122060000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,,2016-06-30,2016-08-04 16:10:01+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,95894000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,,2016-06-30,2016-08-04 16:10:01+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,,2016-06-30,2016-08-04 16:10:01+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,51759000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,,2016-06-30,2016-08-04 16:10:01+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2458000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,,2016-06-30,2016-08-04 16:10:01+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,150111000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,,2016-06-30,2016-08-04 16:10:01+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,8149000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,,2016-06-30,2016-08-04 16:10:01+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,23000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,,2016-06-30,2016-08-04 16:10:01+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,439000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,,2016-06-30,2016-08-04 16:10:01+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,462000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,,2016-06-30,2016-08-04 16:10:01+00:00,,totalassets,Total Assets,=,debit,usd,158722000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,,2016-06-30,2016-08-04 16:10:01+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2466000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,,2016-06-30,2016-08-04 16:10:01+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8274000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,,2016-06-30,2016-08-04 16:10:01+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,10740000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,,2016-06-30,2016-08-04 16:10:01+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1425000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,,2016-06-30,2016-08-04 16:10:01+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1425000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,,2016-06-30,2016-08-04 16:10:01+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,12165000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,,2016-06-30,2016-08-04 16:10:01+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,,2016-06-30,2016-08-04 16:10:01+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,354791000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,,2016-06-30,2016-08-04 16:10:01+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-208243000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,,2016-06-30,2016-08-04 16:10:01+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,9000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,,2016-06-30,2016-08-04 16:10:01+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,146557000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,,2016-06-30,2016-08-04 16:10:01+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,146557000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,,2016-06-30,2016-08-04 16:10:01+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,146557000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,,2016-06-30,2016-08-04 16:10:01+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,158722000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q3,,2016-09-30,2016-11-03 16:15:04+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,50480000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q3,,2016-09-30,2016-11-03 16:15:04+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q3,,2016-09-30,2016-11-03 16:15:04+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,80515000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q3,,2016-09-30,2016-11-03 16:15:04+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2459000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q3,,2016-09-30,2016-11-03 16:15:04+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,133454000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q3,,2016-09-30,2016-11-03 16:15:04+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,8047000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q3,,2016-09-30,2016-11-03 16:15:04+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,435000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q3,,2016-09-30,2016-11-03 16:15:04+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,23000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q3,,2016-09-30,2016-11-03 16:15:04+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,439000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q3,,2016-09-30,2016-11-03 16:15:04+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,897000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q3,,2016-09-30,2016-11-03 16:15:04+00:00,,totalassets,Total Assets,=,debit,usd,142398000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q3,,2016-09-30,2016-11-03 16:15:04+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2770000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q3,,2016-09-30,2016-11-03 16:15:04+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8496000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q3,,2016-09-30,2016-11-03 16:15:04+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,11266000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q3,,2016-09-30,2016-11-03 16:15:04+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1255000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q3,,2016-09-30,2016-11-03 16:15:04+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1255000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q3,,2016-09-30,2016-11-03 16:15:04+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,12521000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q3,,2016-09-30,2016-11-03 16:15:04+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q3,,2016-09-30,2016-11-03 16:15:04+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,357433000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q3,,2016-09-30,2016-11-03 16:15:04+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-227534000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q3,,2016-09-30,2016-11-03 16:15:04+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-22000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q3,,2016-09-30,2016-11-03 16:15:04+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,129877000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q3,,2016-09-30,2016-11-03 16:15:04+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,129877000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q3,,2016-09-30,2016-11-03 16:15:04+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,129877000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q3,,2016-09-30,2016-11-03 16:15:04+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,142398000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,,2017-03-31,2017-05-09 16:27:17+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,25433000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,,2017-03-31,2017-05-09 16:27:17+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,73669000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,,2017-03-31,2017-05-09 16:27:17+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2048000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,,2017-03-31,2017-05-09 16:27:17+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,101150000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,,2017-03-31,2017-05-09 16:27:17+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4707000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,,2017-03-31,2017-05-09 16:27:17+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,,2017-03-31,2017-05-09 16:27:17+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,23000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,,2017-03-31,2017-05-09 16:27:17+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,439000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,,2017-03-31,2017-05-09 16:27:17+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,462000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,,2017-03-31,2017-05-09 16:27:17+00:00,,totalassets,Total Assets,=,debit,usd,106319000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,,2017-03-31,2017-05-09 16:27:17+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2384000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,,2017-03-31,2017-05-09 16:27:17+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8207000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,,2017-03-31,2017-05-09 16:27:17+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,10591000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,,2017-03-31,2017-05-09 16:27:17+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1006000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,,2017-03-31,2017-05-09 16:27:17+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1006000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,,2017-03-31,2017-05-09 16:27:17+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,11597000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,,2017-03-31,2017-05-09 16:27:17+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,,2017-03-31,2017-05-09 16:27:17+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,,2017-03-31,2017-05-09 16:27:17+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,360181000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,,2017-03-31,2017-05-09 16:27:17+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-265400000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,,2017-03-31,2017-05-09 16:27:17+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-59000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,,2017-03-31,2017-05-09 16:27:17+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,94722000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,,2017-03-31,2017-05-09 16:27:17+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,94722000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,,2017-03-31,2017-05-09 16:27:17+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,94722000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,,2017-03-31,2017-05-09 16:27:17+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,106319000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,,2017-06-30,2017-08-03 16:31:14+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,22937000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,,2017-06-30,2017-08-03 16:31:14+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,63622000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,,2017-06-30,2017-08-03 16:31:14+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2535000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,,2017-06-30,2017-08-03 16:31:14+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,89094000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,,2017-06-30,2017-08-03 16:31:14+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3956000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,,2017-06-30,2017-08-03 16:31:14+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,,2017-06-30,2017-08-03 16:31:14+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,23000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,,2017-06-30,2017-08-03 16:31:14+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,812000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,,2017-06-30,2017-08-03 16:31:14+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,835000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,,2017-06-30,2017-08-03 16:31:14+00:00,,totalassets,Total Assets,=,debit,usd,93885000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,,2017-06-30,2017-08-03 16:31:14+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3275000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,,2017-06-30,2017-08-03 16:31:14+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8544000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,,2017-06-30,2017-08-03 16:31:14+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,11819000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,,2017-06-30,2017-08-03 16:31:14+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,925000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,,2017-06-30,2017-08-03 16:31:14+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,925000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,,2017-06-30,2017-08-03 16:31:14+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,12744000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,,2017-06-30,2017-08-03 16:31:14+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,,2017-06-30,2017-08-03 16:31:14+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,,2017-06-30,2017-08-03 16:31:14+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,364775000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,,2017-06-30,2017-08-03 16:31:14+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-283600000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,,2017-06-30,2017-08-03 16:31:14+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-49000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,,2017-06-30,2017-08-03 16:31:14+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,81126000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,,2017-06-30,2017-08-03 16:31:14+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,81141000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,,2017-06-30,2017-08-03 16:31:14+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,81141000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,,2017-06-30,2017-08-03 16:31:14+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,93885000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q3,,2017-09-30,2017-11-02 16:07:22+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,24775000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q3,,2017-09-30,2017-11-02 16:07:22+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,50961000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q3,,2017-09-30,2017-11-02 16:07:22+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1871000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q3,,2017-09-30,2017-11-02 16:07:22+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,77607000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q3,,2017-09-30,2017-11-02 16:07:22+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3606000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q3,,2017-09-30,2017-11-02 16:07:22+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q3,,2017-09-30,2017-11-02 16:07:22+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,23000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q3,,2017-09-30,2017-11-02 16:07:22+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,789000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q3,,2017-09-30,2017-11-02 16:07:22+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,812000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q3,,2017-09-30,2017-11-02 16:07:22+00:00,,totalassets,Total Assets,=,debit,usd,82025000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q3,,2017-09-30,2017-11-02 16:07:22+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2691000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q3,,2017-09-30,2017-11-02 16:07:22+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6212000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q3,,2017-09-30,2017-11-02 16:07:22+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,8903000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q3,,2017-09-30,2017-11-02 16:07:22+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,834000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q3,,2017-09-30,2017-11-02 16:07:22+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,834000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q3,,2017-09-30,2017-11-02 16:07:22+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,9737000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q3,,2017-09-30,2017-11-02 16:07:22+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q3,,2017-09-30,2017-11-02 16:07:22+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q3,,2017-09-30,2017-11-02 16:07:22+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,365262000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q3,,2017-09-30,2017-11-02 16:07:22+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-292953000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q3,,2017-09-30,2017-11-02 16:07:22+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-21000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q3,,2017-09-30,2017-11-02 16:07:22+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,72288000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q3,,2017-09-30,2017-11-02 16:07:22+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,72288000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q3,,2017-09-30,2017-11-02 16:07:22+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,72288000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q3,,2017-09-30,2017-11-02 16:07:22+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,82025000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,,2018-03-31,2018-05-03 16:59:09+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,19721000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,,2018-03-31,2018-05-03 16:59:09+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,38577000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,,2018-03-31,2018-05-03 16:59:09+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,835000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,,2018-03-31,2018-05-03 16:59:09+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,59133000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,,2018-03-31,2018-05-03 16:59:09+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2935000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,,2018-03-31,2018-05-03 16:59:09+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,146000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,,2018-03-31,2018-05-03 16:59:09+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,24000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,,2018-03-31,2018-05-03 16:59:09+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,791000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,,2018-03-31,2018-05-03 16:59:09+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,961000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,,2018-03-31,2018-05-03 16:59:09+00:00,,totalassets,Total Assets,=,debit,usd,63029000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,,2018-03-31,2018-05-03 16:59:09+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1024000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,,2018-03-31,2018-05-03 16:59:09+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4008000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,,2018-03-31,2018-05-03 16:59:09+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,5032000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,,2018-03-31,2018-05-03 16:59:09+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,664000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,,2018-03-31,2018-05-03 16:59:09+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,664000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,,2018-03-31,2018-05-03 16:59:09+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,5696000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,,2018-03-31,2018-05-03 16:59:09+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,,2018-03-31,2018-05-03 16:59:09+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,,2018-03-31,2018-05-03 16:59:09+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,366214000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,,2018-03-31,2018-05-03 16:59:09+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-308850000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,,2018-03-31,2018-05-03 16:59:09+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-31000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,,2018-03-31,2018-05-03 16:59:09+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,57333000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,,2018-03-31,2018-05-03 16:59:09+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,57333000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,,2018-03-31,2018-05-03 16:59:09+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,57333000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,,2018-03-31,2018-05-03 16:59:09+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,63029000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,,2018-06-30,2018-08-09 17:07:08+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,24601000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,,2018-06-30,2018-08-09 17:07:08+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,29027000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,,2018-06-30,2018-08-09 17:07:08+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,547000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,,2018-06-30,2018-08-09 17:07:08+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,54175000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,,2018-06-30,2018-08-09 17:07:08+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,403000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,,2018-06-30,2018-08-09 17:07:08+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,142000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,,2018-06-30,2018-08-09 17:07:08+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,813000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,,2018-06-30,2018-08-09 17:07:08+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,955000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,,2018-06-30,2018-08-09 17:07:08+00:00,,totalassets,Total Assets,=,debit,usd,55533000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,,2018-06-30,2018-08-09 17:07:08+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,757000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,,2018-06-30,2018-08-09 17:07:08+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3990000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,,2018-06-30,2018-08-09 17:07:08+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,4747000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,,2018-06-30,2018-08-09 17:07:08+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,576000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,,2018-06-30,2018-08-09 17:07:08+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,576000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,,2018-06-30,2018-08-09 17:07:08+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,5323000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,,2018-06-30,2018-08-09 17:07:08+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,,2018-06-30,2018-08-09 17:07:08+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,,2018-06-30,2018-08-09 17:07:08+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,366771000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,,2018-06-30,2018-08-09 17:07:08+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-316552000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,,2018-06-30,2018-08-09 17:07:08+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-9000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,,2018-06-30,2018-08-09 17:07:08+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,50210000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,,2018-06-30,2018-08-09 17:07:08+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,50210000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,,2018-06-30,2018-08-09 17:07:08+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,50210000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,,2018-06-30,2018-08-09 17:07:08+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,55533000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,,2018-09-30,2018-11-09 17:24:02+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,31917000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,,2018-09-30,2018-11-09 17:24:02+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,789000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,,2018-09-30,2018-11-09 17:24:02+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,14433000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,,2018-09-30,2018-11-09 17:24:02+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1847000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,,2018-09-30,2018-11-09 17:24:02+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,48986000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,,2018-09-30,2018-11-09 17:24:02+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,108000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,,2018-09-30,2018-11-09 17:24:02+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,140000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,,2018-09-30,2018-11-09 17:24:02+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,,2018-09-30,2018-11-09 17:24:02+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,140000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,,2018-09-30,2018-11-09 17:24:02+00:00,,totalassets,Total Assets,=,debit,usd,49234000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,,2018-09-30,2018-11-09 17:24:02+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,604000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,,2018-09-30,2018-11-09 17:24:02+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3277000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,,2018-09-30,2018-11-09 17:24:02+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,3881000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,,2018-09-30,2018-11-09 17:24:02+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,442000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,,2018-09-30,2018-11-09 17:24:02+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,442000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,,2018-09-30,2018-11-09 17:24:02+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,4323000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,,2018-09-30,2018-11-09 17:24:02+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,,2018-09-30,2018-11-09 17:24:02+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,,2018-09-30,2018-11-09 17:24:02+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,367146000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,,2018-09-30,2018-11-09 17:24:02+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-322232000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,,2018-09-30,2018-11-09 17:24:02+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-3000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,,2018-09-30,2018-11-09 17:24:02+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,44911000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,,2018-09-30,2018-11-09 17:24:02+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,44911000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,,2018-09-30,2018-11-09 17:24:02+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,44911000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,,2018-09-30,2018-11-09 17:24:02+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,49234000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,65587000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,45000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1400000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4174000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1530000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,72736000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1569000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1569000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,,totalassets,Total Assets,=,debit,usd,74305000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,191000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2344000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5746000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1004000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,9285000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,325000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1009000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1334000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,10619000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,235828000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-174452000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,139000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,61515000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,61515000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,2171000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,63686000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,,2019-03-31,2019-05-15 07:23:37+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,74305000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,55274000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,699000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6416000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,2123000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,64512000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,3812000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3812000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,,totalassets,Total Assets,=,debit,usd,68324000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,199000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3091000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6147000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1492000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,10929000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,278000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2092000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,2370000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,13299000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,237149000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-184323000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,140000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,52966000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,52966000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,2059000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,55025000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,,2019-06-30,2019-08-12 06:12:24+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,68324000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,47151000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,703000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4483000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1315000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,53652000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4827000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4827000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,,totalassets,Total Assets,=,debit,usd,58479000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,197000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2691000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5776000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1849000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,10513000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,218000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2919000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,3137000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,13650000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalliabilitiesandequity,redeemablenoncontrollinginterest,Redeemable Noncontrolling Interest,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,238906000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-195955000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,123000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,43074000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,43074000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,1755000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,44829000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,,2019-09-30,2019-11-13 07:22:47+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,58479000.0
